+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Portal Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Portal Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Antibody Drug Conjugates Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Antibody Drug Conjugates Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 210 Pages
  • Global
From
From
From
Drug Repurposing Service Providers Market, 2020-2030 - Product Thumbnail Image

Drug Repurposing Service Providers Market, 2020-2030

  • Report
  • July 2020
  • 215 Pages
  • Global
From
Remdesivir Global Market Report 2024 - Product Thumbnail Image

Remdesivir Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Invasive Fungal Infections Global Market Report 2024 - Product Thumbnail Image

Invasive Fungal Infections Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Atrial Fibrillation - Pipeline Insight, 2024 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
From
From
From
Multidrug Resistant Bacteria Global Market Report 2024 - Product Thumbnail Image

Multidrug Resistant Bacteria Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Loading Indicator